SEC Form 4 · accession 0001567619-18-005885
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Pendarvis
Officer — Chief Administrative Officer
Period of report
Nov 9, 2018
Accepted (ET)
Nov 13, 2018 · 6:13 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common StockF1 | Nov 9, 2018 | F | 854 | $106.94 | D | 106,318 | D | |
| ResMed Common StockF2 | Nov 9, 2018 | F | 1,083 | $106.94 | D | 105,235 | D | |
| ResMed Common StockF3 | Nov 9, 2018 | F | 1,199 | $106.94 | D | 104,036 | D | |
| ResMed Common Stock | Nov 12, 2018 | M | 1,717 | $58.24 | A | 105,753 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock OptionsF4 | $58.24 | Nov 12, 2018 | M | 1,717 | D | Nov 11, 2018 | Nov 19, 2022 | ResMed Common Stock | 1,717 | 0 | D |
Explanation of responses
- F1Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/16/2017.
- F2Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/19/2015.
- F3Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/16/2016.
- F4Represents date incentive stock options first became exercisable.